Business as usual for drug companies

  • Despite Trump’s plan to lower drug prices companies still hiked prices far more often than they cut them. This year through the end of July, there were 4,412 brand-name drug price increases and 46 price cuts, a ratio of 96-to-1.
  • Pharma continues to try and confuse the issue of drug pricing by blaming hospitals and PBM’s.

Continue reading

Pharma learns a hard political lesson

KEY TAKEAWAY: Shares of biotechnology and pharmaceutical companies retreated after President-elect Donald Trump vowed in a magazine article to crack down on drug prices. Drug stocks fell after Mr. Trump was quoted in a Time Person of the Year article as saying: “I’m going to bring down drug prices.”  Better put that champagne on ice. Continue reading